Bioscience

Stem-cell research concerns biotech leader

March 29, 2009

By Flinn Foundation

[Source: Ken Alltucker, Arizona Republic] Arizona’s scientists and citizens are missing out on a potential lucrative source of research funds and medical benefits because of the state’s strict limits on embryonic stem-cell research, a top biotechnology official said.

James Greenwood, president of the Washington, D.C.-based Biotechnology Industry Organization, said that Arizona and other states that limit such research methods may not realize the benefits from President Barack Obama’s move earlier this month to reverse a ban on federal funding of the controversial research.

For more information click here.